Search
for
Sort by
Research 961–990 of 1000+
- Diagnosis, Pathogenesis and Management of Polycystic Ovary Syndrome
- The emerging roles of N6-methyladenosine (m6A) deregulation in polycystic ovary syndrome
- Premature hair graying: a multifaceted phenomenon
- Prolactin: A Mammalian Stress Hormone and Its Role in Cutaneous Pathophysiology
- Anorexia nervosa and reproduction: connecting brain to gonads
- Autistic-undisciplined thinking in the practice of medical trichology
- Effects of supplementation with two probiotic strains (Lactobacillus helveticus and Bifidobacterium longum) on hormonal status, oxidative stress, and clinical symptoms in women with polycystic ovary syndrome: a randomized clinical trial
- Anabolic–Androgenic Steroids and Brain Damage: A Review of Evidence and Medico-Legal Implications
- Efficacy, tolerability, and safety of montelukast versus finasteride for the treatment of moderate acne in women: A prospective, randomized, single‐blinded, active‐controlled trial
- Patient characteristics associated with symptoms of anxiety, depression, and reduced body appreciation in women with polycystic ovary syndrome
- Impact of subclinical hypothyroidism on endocrine features in patients with polycystic ovary syndrome
- Unmasking Melasma: Confronting the Treatment Challenges
- Topical Spironolactone in the Treatment of Evaporative Dry Eye Disease
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- Cutaneous manifestations of endocrine diseases in children
- Androgenetic Alopecia: a Review and Emerging Treatments
- Telogen Effluvium
- Spironolactone versus Bicalutamide for Female Pattern Hair Loss: A 24-Month Unicenter Retrospective Comparative Study of Effectiveness and Safety
- Treatment of Chemotherapy Induced Alopecia
- Lipid nanocarriers as innovative strategies for hair regrowth
- Pharmacovigilance profiles of three generations of mineralocorticoid receptor antagonists and network toxicology analysis
- Androgenetic Alopecia in Polycystic Ovary Syndrome: A Cutaneous Marker of Systemic Metabo-inflammatory and Endocrine Dysfunction: A Narrative Review
- Characterization and Management of Androgenetic Alopecia in Transgender and Gender-Diverse Individuals: A Narrative Review
- Pathophysiology of Androgenetic Alopecia and Implications for Treatment: An Overview of Current Literature
- Intramuscular Compound Betamethasone for the Treatment of Telogen Effluvium: A Single‐Center Real‐World Study
- Perspective Chapter: Beyond BMI – Rethinking Obesity Assessment in Women’s Health
- The Role of Vitamin D and Testosterone Levels with Hair Loss among Females with Coronavirus Disease
- Introductory Chapter: Learning and Recognizing the Post-COVID Syndromes
- Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment
- Dietary and Genetic Aspects of Polycystic Ovary Syndrome (PCOS) in Polish Women-Part II: Association of